This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Multitude, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Junli Liu in Antibody Development
Introduction
Junli Liu is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her work focuses on therapeutic and diagnostic applications, showcasing her innovative spirit and dedication to advancing medical science.
Latest Patents
Junli Liu holds a patent for "Antibodies specific to MUC18." This patent details antibodies that target MUC18, also known as MCAM or CD146. The applications of these antibodies are crucial for therapeutic and diagnostic purposes. The patent also includes information on chimeric antigen receptors (CARs) that incorporate an extracellular antigen-binding fragment that binds MUC18, along with immune cells expressing such receptors.
Career Highlights
Throughout her career, Junli Liu has demonstrated a commitment to research and innovation. She is currently associated with Multitude, Inc., where she continues to explore the potential of her inventions in the medical field. Her work has the potential to impact cancer treatment and other diseases significantly.
Collaborations
Junli Liu has collaborated with notable colleagues, including Bing Hou and Wei Wang. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.
Conclusion
Junli Liu's contributions to antibody development and her innovative research at Multitude, Inc. highlight her role as a leading inventor in the biotechnology field. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.